| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.67B | — | -5.2% |
| R&D Expense | $16.0M | — | -11.1% |
| SG&A Expense | $639.0M | — | +6.9% |
| Operating Income | $392.8M | — | +545.7% |
| Pre-tax Income | -$168.2M | — | +37.1% |
| Income Tax | -$20.9M | — | +67.3% |
| Net Income | -$146.9M | — | +27.5% |
| EPS (Basic) | -$0.51 | — | +28.2% |
| EPS (Diluted) | -$0.51 | — | +28.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.34B | -28.6% | -46.9% |
| Short-term Investments | $172.3M | -84.3% | -93.2% |
| Accounts Receivable | $1.26B | -1.2% | +6.3% |
| Inventory | $395.1M | +3.8% | -4.4% |
| Current Assets | $3.55B | -30.9% | -53.6% |
| Total Assets | $41.38B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $238.3M | — | +15.2% |
| Capital Expenditures | $133.4M | — | -48.4% |
| Investing Cash Flow | $849.1M | — | +151.3% |
| Financing Cash Flow | -$1.78B | — | -437.4% |
| Free Cash Flow | $104.8M | — | +302.9% |
| -31.7% |
| Current Liabilities | $11.77B | -4.8% | +94.3% |
| Long-term Debt | $18.02B | -3.4% | -28.9% |
| Total Liabilities | $35.70B | -4.0% | -11.9% |
| Stockholders' Equity | $5.63B | -2.3% | -71.9% |